Lupin's Somerset facility gets Form-483 with six observations after US FDA inspection May 19, 2024 10:17 AM 2 Min Read
Lupin Limited has announced that the US Food and Drug Administration (FDA) conducted a pre-approval inspection of its manufacturing facility in Somerset, New Jersey. The inspection, which took place from May 7 to May 17, 2024, concluded with the issuance …